Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3B Open-Label Follow-on Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women

NCT02858037 is registered in ClinicalTrials.gov with International Partnership for Microbicides, Inc. as lead sponsor.

NCT NCT02858037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02858037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3B Open-Label Follow-on Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women
Lead sponsor
International Partnership for Microbicides, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 18, 2016
Completion date
October 10, 2018
Enrollment
1,456 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus